INVO Bioscience (NASDAQ:INVO – Get Free Report) and Cochlear (OTCMKTS:CHEOY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.
Earnings and Valuation
This table compares INVO Bioscience and Cochlear’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|INVO Bioscience||$1.18 million||3.14||-$10.89 million||($15.86)||-0.10|
Cochlear has lower revenue, but higher earnings than INVO Bioscience. INVO Bioscience is trading at a lower price-to-earnings ratio than Cochlear, indicating that it is currently the more affordable of the two stocks.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of current recommendations and price targets for INVO Bioscience and Cochlear, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Insider and Institutional Ownership
17.3% of INVO Bioscience shares are owned by institutional investors. Comparatively, 0.1% of Cochlear shares are owned by institutional investors. 10.4% of INVO Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Cochlear beats INVO Bioscience on 5 of the 8 factors compared between the two stocks.
About INVO Bioscience
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.